Updated version 3 - SpaceX aims at US wireless carriers through spectrum acquisition

路透社2026/10/08 21:21

Show original

Reuters, October 8 – SpaceX (SPCX.O) reached an agreement on Thursday to acquire a nationwide portfolio of low-frequency spectrum, enabling Elon Musk’s satellite company to directly challenge traditional US wireless giants at the orbital level. While Starlink Mobile’s current global 2 GHz mid-band spectrum provides high bandwidth capacity, the new spectrum will allow its signals to penetrate obstacles. The financial terms of the agreement were not disclosed. Low-frequency bands are highly sought after for their longer transmission distance and ability to penetrate dense structures such as walls and tree cover, helping to solve a major technical obstacle previously faced by satellite-based mobile networks. By combining nationwide low-frequency radio waves with high-frequency space transmission capabilities, SpaceX is positioning Starlink Mobile as a service that can completely bypass traditional base stations and challenge the wireless oligopoly both in terms of broad coverage and reliable indoor signal. The deal intensifies competitive pressure on traditional carriers, transforming satellite direct-to-device technology from a supplementary safety feature for remote dead zones into a full-fledged commercial competitor capable of replacing terrestrial cellular networks. Shares of T-Mobile US (TMUS.O), Verizon (VZ.N), and AT&T (T.N) all fell more than 6.5% in after-hours trading. The transaction involves acquiring 100% of the nationwide 800 MHz spectrum portfolio held by private equity firm Grain Management, pending regulatory approval from the Federal Communications Commission (FCC). Grain acquired this spectrum earlier this year from T-Mobile. Crucially, most existing, unmodified mobile phones already support the 800 MHz band, so consumers do not need to purchase dedicated satellite phones. The FCC this week also approved Starlink Mobile’s application for its second-generation satellite constellation, authorizing SpaceX to launch 15,000 satellites worldwide optimized for the 2 GHz band. This new constellation will operate in very low Earth orbit, providing ordinary phones with broader bandwidth and low-latency connections. (For the convenience of non-native English speakers, Reuters automatically translates its reports into several other languages. Automated translations may contain inaccuracies or lack necessary context; Reuters does not guarantee the accuracy of automated translation and provides it solely as a convenience for readers. Reuters is not liable for any damage or loss resulting from the use of automated translation.)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium; IPO price falls to lower range at $14.

According to Zhitong Finance APP, TRex Bio Inc., an early-stage biotechnology company focused on autoimmune and inflammatory diseases, raised 116.7 million dollars through its IPO, pricing at the lower end of its indicated range.

智通财经•2026/10/09 07:07

EBA strengthens risk review of European banks’ sovereign bonds: risk exposure remains controllable

(1) The head of the European Banking Authority (EBA) stated that European banking regulators are conducting additional reviews regarding the risks associated with the trillions of euros in sovereign bond portfolios held by banks. (2) According to the official, as the yields on government bonds in some core European countries have soared to multi-year highs, the government debt investment portfolios held by banks require enhanced monitoring. (3) Currently, the relevant risk exposures still appear to be "within controllable ranges." (4) The net interest income generated from bonds has largely offset the impact of declining bond prices on the economic value of banks' equity. (5) He said, "So far, we have not seen banks suffer significant losses as a result of the current situation, and we are confident that regulators are taking the necessary responsive measures."

智通财经•2026/10/09 07:06

Small molecule biotechnology company Iambic Therapeutics (IAM.US) sets IPO price at $15-17 per share, plans to raise $150 millions

According to Jinse Finance, it has been reported that Iambic Therapeutics (IAM.US), a biotechnology company developing small-molecule anti-cancer therapies based on its self-developed artificial intelligence (AI) platform and currently in Phase I clinical trials, announced its IPO terms on Thursday. The San Diego, California-based company plans to raise $150 million by offering 9.4 million shares at a price range of $15 to $17 per share. Some investors have already expressed their intention to purchase $60 million worth of shares in this offering, accounting for 40% of the deal. At the midpoint of the proposed price range, Iambic Therapeutics would have a fully diluted market value of $809 million.

智通财经•2026/10/09 07:06

3D printing materials supplier Amaero (AMRO.US) restarts US IPO with fundraising amount plunging 60% to $20 million

According to information from Zhitong Finance APP, Amaero (AMRO.US), a producer specializing in titanium and refractory metal powders for 3D printing in the defense and aerospace sectors, has resumed its initial public offering (IPO) plans in the United States as of Thursday, submitting new documents to the U.S. Securities and Exchange Commission (SEC) revealing a reduced offering size. The company is currently listed on the Australian Securities Exchange and had previously attempted a cross-listing on Nasdaq in September, but postponed the listing due to unfavorable market conditions. The exact timing of the IPO remains undetermined.

智通财经•2026/10/09 07:06